613
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Ophthalmic Disparities in Transgender Patients

, &
Pages 426-431 | Received 12 Nov 2015, Accepted 10 Feb 2016, Published online: 29 Apr 2016

REFERENCES

  • Fee E, Brown TM, Laylor J. One size does not fit all in the transgender community. Am J Public Health 2003;93(6):899–900.
  • Witeck B. Cultural change in acceptance of LGBT people: Lessons from social marketing. Am J Orthopsychiatry 2014;84(1):19–22.
  • Arcelus J, Bouman WP, Van Den Noortgate W, Claes L, Witcomb G, Fernandez-Aranda F. Systematic review and meta-analysis of prevalence studies in transsexualism. Eur Psychiatry 2015;30(6):807–15.
  • Conron KJ, Scott G, Stowell GS, Landers SJ. Transgender health in Massachusetts: Results from a household probability sample of adults. American Journal of Public Health 2011;102(1):118–122.
  • Roberts TK, Fantz CR. Barriers to quality health care for the transgender population. Clin Biochem. 2014; 47 (10–11): 983–987.
  • Lim FA, Brown DV Jr, Justin Kim SM. Addressing health care disparities in the lesbian, gay, bisexual, and transgender population: A review of best practices. Am J Nurs. 2014;114(6):24–34; quiz 35, 45.
  • Shires DA, Jaffee K. Factors associated with health care discrimination experiences among a national sample of female-to-male transgender individuals. Health Soc Work. 2015;40(2):134–141.
  • Snelgrove JW, Jasudavisius AM, Rowe BW, Head EM, Bauer GR. “Completely out-at-sea” with “two-gender medicine”: A qualitative analysis of physician-side barriers to providing healthcare for transgender patients. BMC Health Serv Res. 2012;12:110.
  • Obedin-Maliver J, Goldsmith ES, Stewart L, et al. Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education. JAMA 2011;306(9):971–977.
  • Rutherford K, McIntyre J, Daley A, Ross LE. Development of expertise in mental health service provision for lesbian, gay, bisexual and transgender communities. Med Educ. 2012;46(9):903–913.
  • Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16.
  • Andrasik MP, Yoon R, Mooney J, et al. Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials. Prev Sci. 2014;15(3):268–276.
  • Wierckx K, Elaut E, Declercq E, et al. Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: A case-control study. Eur J Endocrinol. 2013;169(4):471–478.
  • Gooren LJ, Wierckx K, Giltay EJ. Cardiovascular disease in transsexual persons treated with cross-sex hormones: Reversal of the traditional sex difference in cardiovascular disease pattern. Eur J Endocrinol. 2014;170(6):809–819.
  • Wierckx K, Mueller S, Weyers S, et al. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med. 2012;9(10):2641–2651.
  • Kraemer B, Noll T, Delsignore A, Milos G, Schnyder U, Hepp U. Finger length ratio (2D:4D) in adults with gender identity disorder. Arch Sex Behav. 2009;38(3):359–363.
  • Hare L, Bernard P, Sanchez FJ, et al. Androgen receptor repeat length polymorphism associated with male-to-female transsexualism. Biol Psychiatry. 2009;65(1):93–96.
  • Bentz EK, Hefler LA, Kaufmann U, Huber JC, Kolbus A, Tempfer CB. A polymorphism of the CYP17 gene related to sex steroid metabolism is associated with female-to-male but not male-to-female transsexualism. Fertil Steril. 2008;90(1):56–59.
  • Heylens G, De Cuypere G, Zucker KJ, et al. Gender identity disorder in twins: A review of the case report literature. The Journal of Sexual Medicine 2012;9(3):751–757.
  • Rametti G, Carrillo B, Gomez-Gil E, et al. Effects of androgenization on the white matter microstructure of female-to-male transsexuals: A diffusion tensor imaging study. Psychoneuroendocrinology 2012;37(8):1261–1269.
  • Zubiaurre-Elorza L, Junque C, Gomez-Gil E, Guillamon A. Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals. J Sex Med. 2014;11(5):1248–1261.
  • Zubiaurre-Elorza L, Junque C, Gomez-Gil E, et al. Cortical thickness in untreated transsexuals. Cereb Cortex 2013;23(12):2855–2862.
  • Soleman RS, Schagen SE, Veltman DJ, et al. Sex differences in verbal fluency during adolescence: A functional magnetic resonance imaging study in gender dysphoric and control boys and girls. J Sex Med. 2013;10(8):1969–1977.
  • Burke SM, Menks WM, Cohen-Kettenis PT, Klink DT, Bakker J. Click-evoked otoacoustic emissions in children and adolescents with gender identity disorder. Arch Sex Behav. 2014;43(8):1515–1523.
  • Flor-Henry P. EEG analysis of male to female transsexuals: Discriminant function and source analysis. Clin EEG Neurosci. 2010;41(4):219–222.
  • Wierckx K, De Zaeytijd J, Elaut E, Heylens G, T’Sjoen G. Bilateral non-arteritic ischemic optic neuropathy in a transsexual woman using excessive estrogen dosage. Arch Sex Behav. 2014;43(2):407–409.
  • Oster JM, Shastri P, Geyer C. Cerebral venous sinus thrombosis after gender reassignment surgery. Gend Med. 2010;7(3):270–275.
  • Asscheman H, T’Sjoen G, Lemaire A, et al. Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: A review. Andrologia 2014;46(7):791–795.
  • Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions. Psychiatry Clin Neurosci. 2010;64(4):341–357.
  • Fontanari AM, Andreazza T, Costa AB, et al. Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder. J Psychiatr Res. 2013;47(10):1546–1548.
  • Fuss J, Biedermann SV, Stalla GK, Auer MK. On the quest for a biomechanism of transsexualism: Is there a role for BDNF? J Psychiatr Res. 2013;47(12):2015–2017.
  • Fuss J, Hellweg R, Van Caenegem E, et al. Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF). Eur Neuropsychopharmacol. 2015;25(1):95–99.
  • Gomez-Gil E, Zubiaurre-Elorza L, Esteva I, et al. Hormone-treated transsexuals report less social distress, anxiety and depression. Psychoneuroendocrinology 2012;37(5):662–670.
  • Nowak A, Majsterek I, Przybylowska-Sygut K, et al. Analysis of the expression and polymorphism of APOE, HSP, BDNF, and GRIN2B genes associated with the neurodegeneration process in the pathogenesis of primary open angle glaucoma. Biomed Res Int. 2015;2015:258281.
  • Junyi L, Na L, Yan J. Mesenchymal stem cells secrete brain-derived neurotrophic factor and promote retinal ganglion cell survival after traumatic optic neuropathy. J Craniofac Surg. 2015;26(2):548–552.
  • Weber AJ, Harman CD. BDNF treatment and extended recovery from optic nerve trauma in the cat. Invest Ophthalmol Vis Sci. 2013;54(10):6594–6604.
  • Bikbova G, Oshitari T, Baba T, Yamamoto S. Neurotrophic factors for retinal ganglion cell neuropathy: With a special reference to diabetic neuropathy in the retina. Curr Diabetes Rev. 2014;10(3):166–176.
  • Cutolo M, Capellino S, Sulli A, et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci. 2006;1089:538–547.
  • Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2(9):777–780.
  • Kacar S, Akdogan M, Kosar Y, et al. Estrogen and cyproterone acetate combination-induced autoimmune hepatitis. J Clin Gastroenterol. 2002;35(1):98–100.
  • Gooren LJ, Kreukels B, Lapauw B, Giltay EJ. (Patho)physiology of cross-sex hormone administration to transsexual people: The potential impact of male-female genetic differences. Andrologia 2015;47(1):5–19.
  • Larsson K, Nordborg C, Moslemi AR, Nordborg E. A Western blot and molecular genetic investigation of the estrogen receptor beta in giant cell arteritis. Clin Exp Rheumatol. 2006;24(2Suppl 41): S17–19.
  • Chen JJ, Costello F, Kardon RH. Sex disparities in neuro-ophthalmologic disorders. Curr Eye Res. 2015;40(2):247–265.
  • Tran C, Du Pasquier RA, Cavassini M, et al. Neuromyelitis optica following CMV primo-infection. J Intern Med. 2007;261(5):500–503.
  • Chen J, Wall M. Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin. 2014;54(1):1–11.
  • Sheets C, Peden M, Guy J. Idiopathic intracranial hypertension in a transgender man. J Neuroophthalmol. 2007;27(4):313–315.
  • Park S, Cheng CP, Lim LT, Gerber D. Secondary intracranial hypertension from testosterone therapy in a transgender patient. Semin Ophthalmol. 2014;29(3):156–158.
  • Klein A, Stern N, Osher E, Kliper E, Kesler A. Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women. Curr Eye Res. 2013;38(9):972–976.
  • Reisner SL, Gamarel KE, Dunham E, Hopwood R, Hwahng S. Female-to-male transmasculine adult health: A mixed-methods community-based needs assessment. J Am Psychiatr Nurses Assoc. 2013;19(5):293–303.
  • Fallin A, Goodin A, Lee YO, Bennett K. Smoking characteristics among lesbian, gay, and bisexual adults. Prev Med. 2015;74:123–130.
  • Reddy A, Edesten C, Hardman-Lea S. A transsexual patient with bilateral central retinal vein occlusions. Eye (Lond). 2000;14 (Pt 1):104–105.
  • Altman K. Facial feminization surgery: Current state of the art. Int J Oral Maxillofac Surg. 2012;41(8):885–894.
  • Spiegel JH. Challenges in care of the transgender patient seeking facial feminization surgery. Facial Plast Surg Clin North Am. 2008;16(2):233–238, viii

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.